GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Applied BioCode 6598.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

25.95

-3.89%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 475.2m

FY2016FY2025

Net income

−TWD 201.2m

FY2016FY2025

Free cash flow

−TWD 235.5m

FY2016FY2025

Shareholders' equity

TWD 643.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 475.2mTWD 343.1mTWD 395.2mTWD 390.3mTWD 320.0mTWD 299.0mTWD 104.7mTWD 37.1mTWD 26.8mTWD 11.8m
Gross profitTWD 260.9mTWD 204.0mTWD 268.7mTWD 234.2mTWD 189.4mTWD 193.5mTWD 53.0mTWD 16.7mTWD 8.9mTWD 4.9m
Research and developmentTWD 298.6mTWD 272.6mTWD 246.0mTWD 238.4mTWD 205.9mTWD 197.0mTWD 217.0mTWD 195.7mTWD 204.5mTWD 137.9m
Operating income−TWD 223.3m−TWD 277.7m−TWD 186.7m−TWD 181.9m−TWD 162.3m−TWD 99.2m−TWD 273.5m−TWD 267.6m−TWD 263.8m−TWD 194.6m
Net income−TWD 201.2m−TWD 260.8m−TWD 164.2m−TWD 184.7m−TWD 165.2m−TWD 103.5m−TWD 280.1m−TWD 268.3m−TWD 263.5m−TWD 135.9m
Diluted earnings per share-1.96-2.54-2.01-2.26-2.02-1.27-3.94-4.52-5.65-3.39

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.01bnTWD 1.21bnTWD 993.2mTWD 1.21bnTWD 1.02bnTWD 1.23bnTWD 719.0mTWD 514.1mTWD 336.8mTWD 478.8m
Cash and short-term investmentsTWD 569.6mTWD 857.5mTWD 604.8mTWD 831.3mTWD 646.1mTWD 847.9mTWD 424.0mTWD 350.6mTWD 248.1mTWD 389.0m
Total liabilitiesTWD 369.5mTWD 336.1mTWD 332.2mTWD 396.4mTWD 116.0mTWD 140.2mTWD 188.4mTWD 81.3mTWD 60.3mTWD 51.2m
DebtTWD 59.6mTWD 19.5mTWD 34.4mTWD 49.1mTWD 58.8mTWD 61.4mTWD 134.7mTWD 8.5m——
Shareholders' equityTWD 643.2mTWD 878.8mTWD 661.0mTWD 816.1mTWD 903.0mTWD 1.09bnTWD 530.6mTWD 432.7mTWD 276.5mTWD 427.6m
Shares outstanding103m103m82m82m82m82m71m59m47m40m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 226.6m−TWD 207.7m−TWD 205.1mTWD 145.9m−TWD 151.8m−TWD 146.7m−TWD 313.8m−TWD 286.7m−TWD 250.4m−TWD 449.0m
Capital spending−TWD 8.8m−TWD 7.4m−TWD 6.4m−TWD 22.1m−TWD 16.3m−TWD 28.0m−TWD 24.3m−TWD 18.6m−TWD 5.7m−TWD 5.5m
Free cash flow−TWD 235.5m−TWD 215.1m−TWD 211.5mTWD 123.7m−TWD 168.0m−TWD 174.7m−TWD 338.2m−TWD 305.3m−TWD 256.0m−TWD 454.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 210.1mTWD 217.1mTWD 116.5mTWD 122.8mTWD 115.9mTWD 120.0mTWD 85.0mTWD 74.9m
Gross profitTWD 148.4mTWD 140.2mTWD 48.6mTWD 77.9mTWD 53.7mTWD 80.7mTWD 45.5mTWD 45.1m
Operating incomeTWD 25.1mTWD 18.0m−TWD 69.2m−TWD 38.5m−TWD 72.9m−TWD 42.8m−TWD 73.6m−TWD 79.3m
Net incomeTWD 28.1mTWD 21.0m−TWD 64.3m−TWD 33.7m−TWD 67.5m−TWD 35.7m−TWD 70.9m−TWD 76.8m
Diluted earnings per share0.280.21-0.63-0.33-0.66-0.35-0.69-0.75
Cash from operationsTWD 25.0m−TWD 31.0m−TWD 66.0m−TWD 19.0m−TWD 77.0m−TWD 69.0m−TWD 58.0m−TWD 59.0m
Capital spending−TWD 3.0m−TWD 1.0m−TWD 3.0m—−TWD 2.0m−TWD 2.0m−TWD 1.0m−TWD 1.0m
Free cash flowTWD 22.0m−TWD 32.0m−TWD 69.0m—−TWD 79.0m−TWD 71.0m−TWD 59.0m−TWD 60.0m
Total assetsTWD 1.07bnTWD 1.09bnTWD 1.01bnTWD 1.03bnTWD 1.01bnTWD 1.18bnTWD 1.21bnTWD 1.25bn
Cash and short-term investmentsTWD 557.3mTWD 542.5mTWD 569.6mTWD 618.2mTWD 636.5mTWD 790.8mTWD 857.5mTWD 893.7m
DebtTWD 20.6mTWD 20.2mTWD 20.8mTWD 19.8mTWD 13.5mTWD 14.8mTWD 17.3mTWD 16.9m
Shareholders' equityTWD 701.5mTWD 675.5mTWD 643.2mTWD 687.6mTWD 709.6mTWD 854.2mTWD 878.8mTWD 918.6m

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin54.9%59.5%68.0%60.0%59.2%64.7%
Operating margin-47.0%-75.6%-40.8%-46.6%-50.7%-33.2%
Net margin-42.3%-76.0%-41.6%-47.3%-51.6%-34.6%
Return on equity-31.3%-29.7%-24.8%-22.6%-18.3%-9.5%
Return on assets-19.9%-21.5%-16.5%-15.2%-16.2%-8.4%
Free cash flow yield-7.2%-6.6%-8.2%6.9%-5.6%-4.9%
Revenue growth38.5%-13.2%1.2%22.0%7.0%185.6%
Earnings growth-22.9%58.8%-11.1%11.8%59.6%-63.0%
Current ratio6.78x8.51x8.24x11.58x13.79x13.12x
Debt to equity0.06x0.02x0.02x0.02x0.01x0.01x
Equity ratio63.5%72.3%66.6%67.3%88.6%88.6%
Interest coverage-140.73x-181.75x-74.46x-65.35x-56.55x-22.99x
R&D as a share of sales62.8%79.5%62.3%61.1%64.3%65.9%
Buybacks as a share of market value0.1%-25.7%-0.1%0.1%-0.2%-14.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.8%9.7%35.2%
Operating income7.1%17.6%0.1%
Net income2.9%14.2%25.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin56.8%60.3%60.8%59.4%
Operating margin-61.2%-54.2%-50.9%-96.9%
Net margin-56.5%-50.6%-48.6%-84.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-11.2-7.9-12.6-13.7-21.3-46.4-9.7-8.6-6.8
Price to sales4.86.05.26.511.016.026.062.067.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.